1. Home
  2. STEL vs CRVS Comparison

STEL vs CRVS Comparison

Compare STEL & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stellar Bancorp Inc.

STEL

Stellar Bancorp Inc.

N/A

Current Price

$37.66

Market Cap

1.7B

Sector

Finance

ML Signal

N/A

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

N/A

Current Price

$17.85

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
STEL
CRVS
Founded
2007
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2017
2016

Fundamental Metrics

Financial Performance
Metric
STEL
CRVS
Price
$37.66
$17.85
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$37.00
$28.00
AVG Volume (30 Days)
929.0K
2.0M
Earning Date
04-29-2026
01-01-0001
Dividend Yield
1.59%
N/A
EPS Growth
N/A
N/A
EPS
1.47
N/A
Revenue
$6,430,000.00
N/A
Revenue This Year
$10.14
N/A
Revenue Next Year
$4.65
N/A
P/E Ratio
$25.63
N/A
Revenue Growth
6.04
N/A
52 Week Low
$24.13
$2.54
52 Week High
$40.21
$26.95

Technical Indicators

Market Signals
Indicator
STEL
CRVS
Relative Strength Index (RSI) 57.46 53.31
Support Level $28.92 $6.65
Resistance Level $40.21 $26.95
Average True Range (ATR) 0.81 1.32
MACD -0.32 -0.71
Stochastic Oscillator 8.18 34.26

Price Performance

Historical Comparison
STEL
CRVS

About STEL Stellar Bancorp Inc.

Stellar Bancorp Inc is a U.S. based bank holding company. Through its subsidiary, Stellar Bank, the company provides a diversified range of commercial banking services predominantly to small to medium sized businesses, professionals, and individual customers. Its offerings include different types of loans, such as mortgage loans, home equity loans, automobile loans, etc.; deposit products, such as checking accounts, commercial accounts, money market accounts, savings accounts, etc.; and other banking services like mobile banking, debit cards, cash management and wire transfer services, letters of credit, and others.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: